ArticleFrontiers in oncology2023

Retraction: MicroRNA-326 functions as a tumor suppressor in breast cancer by targeting ErbB/PI3K signaling pathway.

Frontiers Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.